Top compounds associated with response to SPRR2E


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA SGX-523 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA masitinib GDSC1000 pan-cancer AAC 0.022 0.5
mRNA ML312 CTRPv2 pan-cancer AAC 0.05 0.5
mRNA paclitaxel UHNBreast pan-cancer AAC 0.22 0.5
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.023 0.5
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.022 0.5
mRNA lenvatinib CTRPv2 pan-cancer AAC -0.025 0.5
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.024 0.5
mRNA AT13387 CTRPv2 pan-cancer AAC -0.035 0.5
Download CSV